发明名称 |
Treatment of Central Nervous System Disorders |
摘要 |
The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells. These methods are useful for reducing at least one symptom of the disorder. |
申请公布号 |
US2012077741(A1) |
申请公布日期 |
2012.03.29 |
申请号 |
US201113159623 |
申请日期 |
2011.06.14 |
申请人 |
DELFANI KIOUMARS;JANSON ANN MARIE;KUHN H. GEORG;PLATE KARLHEINZ;SCHANZER ANNE;WACHS FRANK-PETER;ZHAO MING;NEURONOVA AB |
发明人 |
DELFANI KIOUMARS;JANSON ANN MARIE;KUHN H. GEORG;PLATE KARLHEINZ;SCHANZER ANNE;WACHS FRANK-PETER;ZHAO MING |
分类号 |
A61K38/18;A61K48/00;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P29/00;A61P31/00;A61P35/00 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|